3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
5
Parasomnias
3
Neoplasms
3
Tuberous Sclerosis
2
Smith-Magenis Syndrome
2
Lung Neoplasms
2
Autism Spectrum Disorder
2
Angelman Syndrome
2
Weight Loss
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Wake Disorders
1
Sleep Disorders, Circadian Rhythm
1
Relapsed Malignant Solid Tumor
1
Radiodermatitis
1
Radiation Injuries
1
Polycystic Ovary Syndrome
1
Pain
1
Neoplasm Metastasis
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Fatigue
1
Depression
1
Delirium
1
Carcinoma, Non-Small-Cell Lung
1
Cachexia
1
Brain Neoplasms
1
Barrett Esophagus
1
Anorexia
1
Interventions
Low-Level Light Therapy
5
Standard of Care
2
Curcumin
2
triethanolamine
1
eucerin
1
cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion
1
Zinc Oxide
1
Triamcinolone Acetonide
1
Sodium Hypochlorite
1
Radiotherapy, Conformal
1
Practice Guidelines as Topic
1
Melatonin
1
Laser Therapy
1
Gels
1
Dimethyl Sulfoxide
1
Centella asiatica extract
1
Biafine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Radiodermatitis
×
Melatonin
×
Clear all
NCT03716583
2021-09-10
MELADERM
Herlev Hospital
Phase 2
Completed
48 enrolled